IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q2 FY23 results · Jul–Sep 2022
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹541.41 crore and net profit of ₹15.91 crore for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 541.41 | — | — | 565.01 | −4.2% |
| Other income | 5.07 | — | — | 5.16 | −1.7% |
| Total income | 546.48 | — | — | 570.17 | −4.2% |
| Profit before tax | 22.14 | — | — | 46.59 | −52.5% |
| Net profit for the period | 15.91 | — | — | 34.67 | −54.1% |
| EPS, basic (₹) | 2.71 | — | — | 5.91 | −54.1% |
| Net margin (%) | 2.9 | — | 6.1 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 541.41 | 537.88 | +0.7% | 565.01 | −4.2% |
| Other income | 5.06 | 10.51 | −51.9% | 5.15 | −1.7% |
| Total income | 546.47 | 548.39 | −0.4% | 570.16 | −4.2% |
| Profit before tax | 21.90 | 41.62 | −47.4% | 46.81 | −53.2% |
| Net profit for the period | 15.67 | 30.84 | −49.2% | 34.89 | −55.1% |
| EPS, basic (₹) | 2.67 | 5.26 | −49.2% | 5.94 | −55.1% |
| Net margin (%) | 2.9 | 5.7 | 6.2 |
Consolidated
- Filed with BSE
- 16 Nov 2022, 17:24 IST
- Board meeting
- 14 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 16 Nov 2022, 17:24 IST
- Board meeting
- 14 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Audited
- Source
- XBRL filing on BSE